| Application no. and date | 11779654.0 (espacenet) (Federated) (European Patent Register), 20111107 | | Patent/reg. no. and date | DK/EP 2637643, 20141217 | | Publication date | 20130918 | | Priority no. and date | EP 10190461, 20101109 | | EP pub. no. and date |
EP 2637643 20130918 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Base, CH | | Applicant ref. no. | P55081DK01 | | Inventor | SHAH, Navnit Hargovindas, 203 Beverly Hill Road
Clifton, NJ 07012, US,
LEIMINER, Andreas, Schlossweg 5g
79639 Grenzach-Wyhlen, DE,
LINDENSTRUTH, Kai, Joachim-Karnatz-Allee 25
10557 Berlin, DE,
MILLER, Dave Alan, 5 Washington Court
Livingston, NJ 07039, US,
SCHEUBEL, Emmanuel, 5 rue de la Marne
F-68510 Sierentz, FR | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/4035 (2006.01) , A61K 9/16 (2006.01) , A61P 31/14 (2006.01) | | Title | FARMACEUTISK PRÆPARAT TIL BEHANDLING AF HCV-INFEKTIONER | | Int. application no. | EP2011069492 | | Int. publication no. | WO2012062685 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
